Rationale of combined modality therapy for cancer.

D. S. Martin,R. Fugmann,R. Stolfi,P. Hayworth

Published 1974 in Cancer chemotherapy reports. Part 2

ABSTRACT

No abstract is available for this paper.

PUBLICATION RECORD

Publication year
1974
Venue
Cancer chemotherapy reports. Part 2
Publication date
1974-03-01
Fields of study
Medicine
Identifiers
PMID 4363650
External record
Open on Semantic Scholar
Source metadata
Semantic Scholar, PubMed

CITATION MAP

EXTRACTION MAP

CLAIMS

No claims are published for this paper.

CONCEPTS

No concepts are published for this paper.

REFERENCES

In vitro studies on cell‐mediated immunity following surgery in mice sensitized to syngeneic mammary tumors
2006cited by this paper
Immunoglobulin on tumor cells and tumor-induced lymphocyte blastogenesis in human acute leukemia.
1973cited by this paper
Immunotherapy of cancer: regression of intradermal tumors and prevention of growth of lymph node metastases after intralesional injection of living Mycobacterium bovis.
1972cited by this paper
Specific desensitization of resistance against a syngeneic methylcholanthrene-induced sarcoma in C3Hf mice.
1972cited by this paper
Combined chemoimmunostimulation therapy against murine leukemia.
1972cited by this paper
Facilitation of polyoma tumor growth in rats by blocking sera and tumor eluate
1972cited by this paper
Possibilities and problems of immunologic intervention in cancer.
1972cited by this paper
Lymphocyte blastogenesis to human leukemia cells and their relationship to serum factors, immunocompetence, and prognosis.
1972cited by this paper
Immunogenicity of leukemia L1210 cells after neuraminidase treatment.
1972cited by this paper
Combination cancer therapy: Presidential address.
1972cited by this paper
Mediation of immunity to tumor-specific transplantation antigens by RNA inhibition of isograft growth in rats.
1972cited by this paper
Immunotherapy of Cancer: Regression of Tumors after Intralesional Injection of Living Mycobacterium bovis
1971cited by this paper
Chemotherapeutic implications of staging in Hodgkin's disease.
1971cited by this paper
Cellular immunity to nephroblastoma
1971cited by this paper
Evolution of cell-mediated immunity in mice bearing tumors produced by a mammary carcinoma cell line. Influence of tumor growth, surgical removal, and treatment with irradiated tumor cells.
1971cited by this paper
Suggestive evidence that the "blocking antibodies" of tumor-bearing individuals may be antigen--antibody complexes.
1971cited by this paper
Cancer chemotherapy is many things: G.H.A. Clowes Memorial Lecture.
1971cited by this paper
Enhanced growth of primary moloney virus‐induced sarcomas in mice
1971cited by this paper
IMMUNOLOGICAL ENHANCEMENT OF MURINE TUMOR ISOGRAFTS MEDIATED BY RNA FROM LYMPHOID ORGANS OF XENOGENEIC IMMUNIZED ANIMALS
1971cited by this paper
Stimulation or suppression of metastases with graded doses of tumor cells.
1971cited by this paper
A dilute agar colony inhibition (CI) test for studying cell‐mediated immune responses against tumor cells
1971cited by this paper
Serum-mediated inhibition of lymphocyte stimulation by autochthonous human tumors.
1971cited by this paper
De novo malignant tumors in organ transplant recipients.
1971cited by this paper
Concomitant immunity and specific depression of immunity by residual or reinjected syngeneic tumor tissue.
1971cited by this paper
Adoptive chemoimmunotherapy of a moloney lymphoma
1971cited by this paper
Immunofluorescence tests on sera of patients with osteogenic sarcoma.
1971cited by this paper
Protection against spontaneous mouse mammary adenocarcinoma by inoculation of heat‐treated syngeneic mammary tumor cells
1971cited by this paper
Reduced lymphocyte transformation in breast cancer.
1971cited by this paper
Immunotherapy of Cancer: Immunospecific Rejection of Tumors in Recipients of Neuraminidase-Treated Tumor Cells Plus BCG
1971cited by this paper
Phytohemagglutinin (PHA)‐induced transformation of lymphocytes from patients with cancer
1971cited by this paper
Effect of combination treatment with cyclophosphamide and isogeneic or allogeneic spleen and bone marrow cells in leukemic (l1210) mice
1971cited by this paper
RNA‐mediated transfer of tumor immunity —A new model for the immunotherapy of cancer
1971cited by this paper
Tumor immunity.
1970cited by this paper
Transfer of tumor-specific immunity with RNA: demonstration by immune cytolysis of tumor cells in vitro.
1970cited by this paper
Enhanced cures of spontaneous murine mammary tumors with surgery, combination chemotherapy, and immunotherapy.
1970cited by this paper
Colony inhibition studies on blocking and non‐blocking serum effects on cellular immunity to moloney sarcomas
1970cited by this paper
Immunotherapy of Cancer: An Experimental Model in Syngeneic Guinea Pigs
1970cited by this paper
Mediation of Immunity to Tumor Isografts in Mice by Heterologous Ribonucleic Acid
1970cited by this paper
Immunological factors which influence response to immunotherapy in malignant melanoma.
1970cited by this paper
Cancer immunology and the surgeon.
1970cited by this paper
Immunotherapy of primary moloney sarcoma‐virus‐induced tumors
1970cited by this paper
Enhanced cures of spontaneous murine mammary carcinomas with surgery and five-compound combination chemotherapy, and their immunotherapeutic interrelationship.
1970cited by this paper
Transfer of tumor immunity with ribonucleic acid
1970cited by this paper
Immunologic enhancement.
1970cited by this paper
Immunotherapy and chemotherapy of Moloney sarcoma virus-induced tumors in mice.
1969cited by this paper
Modification of tumor regression by immunologic means.
1969cited by this paper
Comparison of the dose- and timesurvival curves for normal hematopoietic and lymphoma colony-forming cells exposed to vinblastine, vincristine, arabinosylcytosine, and amethopterin.
1969cited by this paper
Serum-mediated protection of neoplastic cells from inhibition by lymphocytes immune to their tumor-specific antigens.
1969cited by this paper
Factors pertaining to complete drug-induced remission of tumor in animals and man.
1969cited by this paper
Biochemical events in the animal cell cycle.
1969cited by this paper
Active immunotherapy of L1210 leukaemia applied after the graft of tumour cells.
1969cited by this paper
Combined effects of chemotherapy and immunity against leukemia L1210 in DBA-2 mice.
1969cited by this paper
Studies on serum‐mediated inhibition of cellular immunity to spontaneous mouse mammary tumors
1969cited by this paper
An immunochemotherapeutic system for the treatment of a transplanted Moloney virus-induced lymphoma in mice.
1969cited by this paper
Combined cancer radiotherapy and chemotherapy: The relevance of cell population kinetics and pharmacodynamics.
1969cited by this paper
Evolution of cell-mediated immunity in mice bearing an antigenic tumor. Influence of tumor growth and surgical removal.
1969cited by this paper
Effect of carcinostatic agents on carcinomatous metastasis in the spleen.
1969cited by this paper
Immunologic factors involved in the growth of primary tumors in human or animal hosts
1969cited by this paper
Single versus multiple dose dactinomycin therapy of Wilms's tumor. A controlled co-operative study conducted by the Children's Cancer Study Group A (formerly Acute Leukemia Co-operative Chemotherapy Group A).
1968cited by this paper
The immunologic status of patients with nonlymphomatous cancer.
1968cited by this paper
Biochemical, biological, pharmacologic, toxicologic, kinetic and clinical (subhuman and human) relationships
1968cited by this paper
Immune status of the primary host toward its own methylcholanthrene-induced sarcomas.
1968cited by this paper
Are immunosuppressive anticancer drugs self-defeating?
1968cited by this paper
Host defenses in leukemia and Burkitt's tumor
1968cited by this paper
Synergistic action of cyclophosphamide and 1,3-bis(2-chloroethyl)-1-nitrosourea on a transplanted murine lymphoma.
1968cited by this paper
Increased growth of tumor isotransplants after immunosuppression of the recipient mice by methotrexate or 5-fluoro-2'-deoxyuridine.
1967cited by this paper
Dactinomycin in Wilms' tumor.
1967cited by this paper
Effect of Nucleic Acids from Immune Lymphocytes on Rat Sarcomata
1967cited by this paper
Role of adjuvants in the production of delayed hypersensitivity.
1967cited by this paper
Comparison of the sensitivity of normal hematopoietic and transplanted lymphoma colony-forming cells to chemotherapeutic agents administered in vivo.
1967cited by this paper
Cellular resistance to tumours.
1967cited by this paper
Criteria associated with destruction of leukemia and solid tumor cells in animals.
1967cited by this paper
Influence of bacille Calmette-Guérin infection on polyoma in hamsters and mice.
1966cited by this paper
Chemotherapy in the treatment of leukemia and Wilms' tumor.
1966cited by this paper
Experimental evaluation of potential anticancer agents XV. On the relative rates of growth and host kill of "single" leukemia cells that survive in vivo cytoxan therapy.
1966cited by this paper
Clinical immunologic study of malignant disease: response to tumor transplants and transfer of leukocytes.
1966cited by this paper
Effect of noncarcinogenic and carcinogenic hydrocarbons on antibody-forming cells measured at the cellular level in vitro.
1966cited by this paper
Evidence for an immunological reaction of the host directed against its own actively growing primary tumor.
1966cited by this paper
Role of dactinomycin in the improved survival of children with Wilms' tumor.
1966cited by this paper
SPECIFIC TRANSPLANTATION IMMUNITY IN RELATION TO ROUS SARCOMA VIRUS TUMORIGENESIS IN MICE
1966cited by this paper
Depressed antibody response in the mouse infected with Rauscher leukaemia virus.
1966cited by this paper
Chemotherapy in childhood cancer (except leukemia) An appraisal
1965cited by this paper
THE RELATIONSHIP OF THE CELL CYCLE TO TUMOR GROWTH AND CONTROL OF CELL DIVISION: A REVIEW.
1965cited by this paper
Immunologic responses in cancer patients.
1965cited by this paper
Immunodepressive effect of 3-methylcholanthrene. Antibody formation at the cellular level and reaction against weak antigenic homografts.
1965cited by this paper
IMMUNITY TO SPONTANEOUS AND METHYLCHOLANTHRENE-INDUCED TUMORS IN INBRED MICE.
1964cited by this paper
CHEMOTHERAPEUTIC CURE OF SPONTANEOUS MOUSE CANCER.
1964cited by this paper
COMBINATION THERAPY WITH CYCLOPHOSPHAMIDE AND ZYMOSAN ON A SPONTANEOUS MAMMARY CANCER IN MICE.
1964cited by this paper
A CLONAL SELECTION THEORY OF CHEMICAL CARCINOGENESIS.
1964cited by this paper
Survival of skin homografts in methylcholanthrene-treated mice and in mice with spontaneous mammary cancers.
1962cited by this paper
Host defense mechanisms in the regression of sarcoma 180 in pyridoxine-deficient mice.
1962cited by this paper
On the question of the mechanism of growth of a tumour against isoimmunity.
1962cited by this paper
Production of metastases by treatment with carcinostatic agents. I. Effects of carcinostatic agents on the host.
1961cited by this paper
Gastroduodenal metastases from carcinoma of the breast. An adrenal steroid–induced phenomenon
1961cited by this paper
Studies on the suppression of the homograft response with folic acid antagonists.
1961cited by this paper
Cancer treatment: immunologic and chemotherapeutic interrelationships.
1961cited by this paper
Clinical implications of the interrelationship of tumor size and chemotherapeutic response.
1960cited by this paper
The effectiveness of cyclophosphamide (cytoxan) against well established transplanted rodent tumors.
1960cited by this paper
Demonstration of resistance against methylcholanthrene-induced sarcomas in the primary autochthonous host.
1960cited by this paper
Some effects of cyclophosphamide (cytoxan) on normal mice and mice with L1210 leukemia.
1959cited by this paper

CITED BY

Chimiothérapie et toxicité rénale Chemotherapy and renal toxicity
2008cites this paper
[Chemotherapy and renal toxicity].
2008cites this paper
The lethal activity and repair inhibition capacity of 1-(2-chloroethyl)-3-(2,6-dioxo-3-piperidyl)-1-nitrosourea
2004cites this paper
Toxicological Evaluation of 1,2-Bis(methylsulfonyl)-1-(2-chloroethyl)-2-(methylaminocarbonyl)hydrazine (VNP40101M), a Novel Alkylating Agent with Potential Antitumor Activity, with Intravenous Administration in Rats and Dogs
2002cites this paper
Dose-Intensity, Dose-Escalation, and Dose-Density in the Adjuvant Chemotherapy of Primary, Operable Breast Cancer
2001cites this paper
The role of systemic chemotherapy in the treatment of brain metastases from small-cell lung cancer.
2001cites this paper
Trials of Adjuvant Chemotherapy for Operable Breast Cancer
1991cites this paper
Clinical and Experimental Nephrotoxicity of Cancer Chemotherapeutic Agents
1987cites this paper
Inhibition of DNA synthesis by lonidamine and hyperthermia in human chronic myeloid leukemia cells.
1986cites this paper
Intraarterial 1,3-bis(2-chloroethyl)-1-nitrosourea chemotherapy for the treatment of malignant gliomas of the brain: a preliminary report.
1985cites this paper
Drug prescribing in renal failure: dosing guidelines for adults.
1983cites this paper
Ocular toxicity associated with high-dose carmustine.
1982cites this paper
Nephrotoxicity of semustine (methyl-CCNU) in patients with malignant melanoma receiving adjuvant chemotherapy.
1981cites this paper
The scientific basis for adjuvant chemotherapy.
1981cites this paper
Chemotherapy Programs of the National Prostatic Cancer Project (NPCP)
1980cites this paper
Formulation and biological distribution of radiolabeled 1-(2-chloroethyl)-3-cyclohexyl-1-nitrosourea in an animal tumor model.
1980cites this paper
[Effect of different dosages of chemotherapeutic agents on survival of mice with ascitic tumor (author's transl)].
1979cites this paper
Combination radiotherapy and chemotherapy in murine bladder cancer.
1979cites this paper
Influence of fractionation schedules on the response of a rat brain tumor to therapy with BCNU and radiation.
1979cites this paper
Patterns of Relapse and Survival in Operable Breast Carcinoma with Positive and Negative Axillary Nodes
1978cites this paper
Long-term follow-up study of gastric cancer patients treated with surgery and adjuvant chemotherapy with mitomycin C.
1978cites this paper
Chemotherapy in prevention of the recurrence of resectable cancer.
1978cites this paper
The treatment of lung cancer: Perspectives and critique
1977cites this paper
Adjuvant combination chemotherapy in primary mammary carcinoma: the CMF program.
1977cites this paper
[Integrated treatment of the inoperable bronchial carcinoma (author's transl)].
1977cites this paper
Current dilemmas in the management of non-seminomatous germ cell tumors of the testis.
1977cites this paper
The CMF program for operable breast cancer with positive axillary nodes: Updated analysis on the disease‐free interval, site of relapse and drug tolerance
1977cites this paper
Comparison of 5-fluorouracil and ftorafur. I. Quantitative and qualitative differences in toxicity to mice.
1976cites this paper
Radiotherapy and CCNU in the treatment of high-grade supratentorial astrocytomas.
1976cites this paper
Radiation therapy: results and future possibilities.
1976cites this paper
Cancer chemotherapy: drug combination and multiple modality treatment.
1976cites this paper
Strategy of Cancer Treatment
1976cites this paper
Methotrexate, cyclophosphamide and vincristine (MEV regimen) for non-Hodgkin's lymphoma.
1975cites this paper
The clinical impact of screening and other experimental tumor studies.
1975cites this paper
Combination chemotherapy in breast cancer: a randomized study of 4 versus 5 drugs.
1975cites this paper